Annual Operating Expenses
$234.88 M
+$67.25 M+40.12%
31 December 2023
Summary:
Verve Therapeutics annual total operating expenses is currently $234.88 million, with the most recent change of +$67.25 million (+40.12%) on 31 December 2023. During the last 3 years, it has risen by +$194.25 million (+478.14%). VERV annual operating expenses is now at all-time high.VERV Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$63.77 M
-$1.76 M-2.68%
30 September 2024
Summary:
Verve Therapeutics quarterly total operating expenses is currently $63.77 million, with the most recent change of -$1.76 million (-2.68%) on 30 September 2024. Over the past year, it has increased by +$8.32 million (+15.01%). VERV quarterly operating expenses is now -2.68% below its all-time high of $65.53 million, reached on 30 June 2024.VERV Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.1% | +15.0% |
| 3 y3 years | +478.1% | +171.4% |
| 5 y5 years | - | - |
VERV Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +478.1% | -2.7% | +171.4% |
| 5 y | 5 years | at high | +1621.8% | -2.7% | +853.9% |
| alltime | all time | at high | +1621.8% | -2.7% | +853.9% |
Verve Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $63.77 M(-2.7%) |
| June 2024 | - | $65.53 M(+4.8%) |
| Mar 2024 | - | $62.54 M(+5.8%) |
| Dec 2023 | $234.88 M(+40.1%) | $59.09 M(+6.6%) |
| Sept 2023 | - | $55.45 M(-8.6%) |
| June 2023 | - | $60.68 M(+1.7%) |
| Mar 2023 | - | $59.66 M(+22.5%) |
| Dec 2022 | $167.63 M | $48.72 M(+8.8%) |
| Sept 2022 | - | $44.79 M(+6.2%) |
| June 2022 | - | $42.19 M(+32.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $31.93 M(-1.9%) |
| Dec 2021 | $87.07 M(+114.3%) | $32.54 M(+38.5%) |
| Sept 2021 | - | $23.50 M(+38.5%) |
| June 2021 | - | $16.96 M(+20.6%) |
| Mar 2021 | - | $14.06 M(-20.1%) |
| Dec 2020 | $40.63 M(+197.8%) | - |
| Dec 2020 | - | $17.60 M(+96.2%) |
| Sept 2020 | - | $8.97 M(+34.2%) |
| June 2020 | - | $6.69 M(-9.3%) |
| Mar 2020 | - | $7.37 M |
| Dec 2019 | $13.64 M | - |
FAQ
- What is Verve Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Verve Therapeutics?
- What is Verve Therapeutics annual operating expenses year-on-year change?
- What is Verve Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Verve Therapeutics?
- What is Verve Therapeutics quarterly operating expenses year-on-year change?
What is Verve Therapeutics annual total operating expenses?
The current annual operating expenses of VERV is $234.88 M
What is the all time high annual operating expenses for Verve Therapeutics?
Verve Therapeutics all-time high annual total operating expenses is $234.88 M
What is Verve Therapeutics annual operating expenses year-on-year change?
Over the past year, VERV annual total operating expenses has changed by +$67.25 M (+40.12%)
What is Verve Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of VERV is $63.77 M
What is the all time high quarterly operating expenses for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total operating expenses is $65.53 M
What is Verve Therapeutics quarterly operating expenses year-on-year change?
Over the past year, VERV quarterly total operating expenses has changed by +$8.32 M (+15.01%)